ALBANY, N.Y.--(BUSINESS WIRE)--AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will present at the 21st Annual Oppenheimer Healthcare Conference at 4:30 p.m. ET on Wednesday, November 3, 2010, at The Waldorf-Astoria Hotel in New York. Joseph Gersuk, Executive Vice President and Chief Financial Officer of AngioDynamics, will review the Company’s business strategy and recent corporate developments.
